• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对HIV-1逆转录酶非核苷类抑制剂的耐药性。

Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptase.

作者信息

Bacheler Lee T.

机构信息

Experimental Station, DuPont Pharmaceuticals Company, Wilmington, DE, USA

出版信息

Drug Resist Updat. 1999 Feb;2(1):56-67. doi: 10.1054/drup.1998.0064.

DOI:10.1054/drup.1998.0064
PMID:11504469
Abstract

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are a structurally diverse group of compounds which function as inhibitors of HIV-1 replication in vitro and in vivo. Viral resistance is mediated through alterations in the amino acids which form the allosteric site on the HIV-1 reverse transcriptase to which NNRTIs bind. The rapid emergence of resistant viruses has limited the utility of NNRTI monotherapy; however, recent clinical studies have shown that potent NNRTIs can contribute to profound suppression of HIV replication when used in combination therapy. An understanding of the development of resistance to NNRTIs is critical to the effective use of this class of antiretroviral agents. Copyright 1999 Harcourt Publishers Ltd.

摘要

非核苷类逆转录酶抑制剂(NNRTIs)是一类结构多样的化合物,在体外和体内均发挥HIV-1复制抑制剂的作用。病毒耐药性是通过构成HIV-1逆转录酶变构位点(NNRTIs与之结合)的氨基酸改变介导的。耐药病毒的迅速出现限制了NNRTI单一疗法的应用;然而,最近的临床研究表明,强效NNRTIs在联合治疗中使用时可显著抑制HIV复制。了解对NNRTIs的耐药性发展对于有效使用这类抗逆转录病毒药物至关重要。版权所有1999年哈考特出版有限公司。

相似文献

1
Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptase.对HIV-1逆转录酶非核苷类抑制剂的耐药性。
Drug Resist Updat. 1999 Feb;2(1):56-67. doi: 10.1054/drup.1998.0064.
2
Is there a role for non-nucleoside reverse transcriptase inhibitors in the treatment of HIV infection?非核苷类逆转录酶抑制剂在治疗HIV感染中是否有作用?
Infect Agents Dis. 1994 Dec;3(6):313-23.
3
Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors.与非核苷类逆转录酶抑制剂耐药相关的突变的汇编与流行情况
Antivir Ther. 2009;14(1):103-9.
4
The search for potent, small molecule NNRTIs: A review.强效小分子非核苷类逆转录酶抑制剂的研究进展:综述
Bioorg Med Chem. 2009 Aug 15;17(16):5744-62. doi: 10.1016/j.bmc.2009.06.060. Epub 2009 Jul 3.
5
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.人类免疫缺陷病毒基因耐药性检测对治疗效果的影响研究。
Verh K Acad Geneeskd Belg. 2001;63(5):447-73.
6
Improving non-nucleoside reverse transcriptase inhibitors for first-line treatment of HIV infection: the development pipeline and recent clinical data.改进用于HIV感染一线治疗的非核苷类逆转录酶抑制剂:研发进程及近期临床数据
Curr Opin Drug Discov Devel. 2008 Jul;11(4):458-70.
7
Diphenyl ether non-nucleoside reverse transcriptase inhibitors with excellent potency against resistant mutant viruses and promising pharmacokinetic properties.二苯醚类非核苷逆转录酶抑制剂,对耐药突变病毒具有优异的活性,且具有良好的药代动力学特性。
ChemMedChem. 2009 Jan;4(1):88-99. doi: 10.1002/cmdc.200800262.
8
Structural and biochemical effects of human immunodeficiency virus mutants resistant to non-nucleoside reverse transcriptase inhibitors.对非核苷类逆转录酶抑制剂耐药的人类免疫缺陷病毒突变体的结构和生化效应
Int J Biochem Cell Biol. 2004 Sep;36(9):1735-51. doi: 10.1016/j.biocel.2004.02.026.
9
Non-nucleoside reverse transcriptase inhibitors (NNRTIs): past, present, and future.非核苷类逆转录酶抑制剂(NNRTIs):过去、现在与未来
Chem Biodivers. 2004 Jan;1(1):44-64. doi: 10.1002/cbdv.200490012.
10
Biochemical mechanisms involved in overcoming HIV resistance to nucleoside inhibitors of reverse transcriptase.克服HIV对逆转录酶核苷类抑制剂耐药性所涉及的生化机制。
Drug Resist Updat. 2000 Feb;3(1):30-38. doi: 10.1054/drup.2000.0126.

引用本文的文献

1
Energetic effects for observed and unobserved HIV-1 reverse transcriptase mutations of residues L100, V106, and Y181 in the presence of nevirapine and efavirenz.在奈韦拉平和依非韦伦存在的情况下,对HIV-1逆转录酶中L100、V106和Y181残基的观察到的和未观察到的突变的能量效应。
Bioorg Med Chem Lett. 2008 Feb 1;18(3):969-72. doi: 10.1016/j.bmcl.2007.12.033. Epub 2007 Dec 23.
2
Computational studies and drug design for HIV-1 reverse transcriptase inhibitors of 3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs.3',4'-二-O-(S)-樟脑酰基-(+)-顺式凯刺酮(DCK)类似物作为HIV-1逆转录酶抑制剂的计算研究与药物设计
J Comput Aided Mol Des. 2005 Apr;19(4):243-58. doi: 10.1007/s10822-005-4790-2.
3
Characterization of a subtype D human immunodeficiency virus type 1 isolate that was obtained from an untreated individual and that is highly resistant to nonnucleoside reverse transcriptase inhibitors.
从一名未经治疗的个体中分离出的1型人类免疫缺陷病毒D亚型毒株的特征,该毒株对非核苷类逆转录酶抑制剂具有高度抗性。
J Virol. 2004 May;78(10):5390-401. doi: 10.1128/jvi.78.10.5390-5401.2004.
4
Evolution of human immunodeficiency virus type 1 (HIV-1) resistance mutations in nonnucleoside reverse transcriptase inhibitors (NNRTIs) in HIV-1-infected patients switched to antiretroviral therapy without NNRTIs.在转而接受不含非核苷类逆转录酶抑制剂(NNRTIs)的抗逆转录病毒治疗的HIV-1感染患者中,人类免疫缺陷病毒1型(HIV-1)对NNRTIs耐药突变的演变情况。
Antimicrob Agents Chemother. 2004 Jan;48(1):172-5. doi: 10.1128/AAC.48.1.172-175.2004.
5
Delavirdine: a review of its use in HIV infection.地拉韦啶:其在HIV感染治疗中的应用综述
Drugs. 2000 Dec;60(6):1411-44. doi: 10.2165/00003495-200060060-00013.
6
Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1.广谱非核苷类逆转录酶抑制剂可抑制1型人类免疫缺陷病毒的临床相关突变变体。
Antimicrob Agents Chemother. 1999 Dec;43(12):2893-7. doi: 10.1128/AAC.43.12.2893.